Navigate the procurement process with ease by partnering with CellCarta’s sample management team.
Finding the right samples for your study can be complex, leading to issues with documentation and regular delays.
To accelerate assay development projects, we can consult our in-house biobank, compliant with the Belgian biobank regulation and containing over 5,000 validated, phenotype-characterized samples.
From to reviewing ethics documentation, CellCarta’s expert sample management team performs biospecimen procurement, ensuring your research can progress without delay.
We work with many biospecimen providers locally and globally to access fresh samples that are suited to your study’s needs.
Informed consent forms (ICF) are included with all samples and meticulously reviewed by our team before being approved for research use.
Collaborating with local hospitals, our Institution Review Board (IRB)-approved sample collection protocols allow for timely human tissue procurement from healthy and disease-state donors.
Our IRB-approved on-site blood collection protocol allows for rapid access to blood samples and study initiation.
Choose a biospecimen procurement service provider that is reliable, timely, and quality-focused.
Biobank for Fresh Sample Access
Proper Ethics Documentation
Global Logistics Services
On-Site Collection Protocols
Vast Provider Network
Explore our complementary services to ensure your study’s logistics are well coordinated and kept on-track from end-to-end.
CellCarta's sample management team navigates the full biospecimen procurement process on your behalf, from identifying the right sample providers and managing ethics documentation to ensuring samples match your study's clinical profile. We source from both commercial providers and hospital networks, handling the complexities behind sample logistics for your team. Services are tailored to the scale and requirements of your study.
Through our local and global biospecimen provider network, we source a broad range of sample types including peripheral blood mononuclear cells (PBMCs), bone marrow-derived mast cells (BMMCs), whole blood, plasma, serum, bone marrow aspirate (BMA), and fresh tumor tissue.
Through our partnership with local hospital networks, we can also facilitate rapid access to valuable clinical samples following collection. This includes samples from healthy or disease-state donors (e.g., leukapheresis samples from healthy and HIV donors, fresh lung tumor tissue, etc.).